Minor Injuries Units
Primary Care Services
End of Life Care
Trust HQ, Tatchbury Mount Calmore
Southampton SO40 2RZ
Tel No: 023 8087 4000
Participants will be randomised to either taking the study drug (subcutaneous liraglutide (max dose 3mg daily)) or a placebo for 6 months.
To take part you must meet the following criteria:
Have a diagnosis of schizophrenia, schizo-affective disorder or first episode psychosis.
Aged between 18 – 75 years
Treatment with an antipsychotic medication for a minimum of one month
Be either obese or overweight with at least one weight related consequence such as hypertension.
Ability and willingness to take the study drug (liraglutide) or placebo.
If you would like to take part or want more information please contact the study lead:
Study Contact: Clare Whicher
Tel: 023 8047 5258